Sierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare Conference

Rhea-AI Summary

Sierra Oncology (NASDAQ: SRRA) announced its participation in the 32nd Annual Oppenheimer Healthcare Conference, scheduled for March 15-17, 2022. CEO Stephen Dilly will present on March 15 at 3:20 PM ET, discussing the company’s mission to deliver targeted therapies for rare cancers. A replay of the presentation will be accessible on the corporate website's Events & Webcast section for 30 days post-conference. Sierra Oncology focuses on advancing cancer treatments through a deep understanding of disease mechanisms and innovative therapeutic approaches.

SAN MATEO, Calif.--(BUSINESS WIRE)-- Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the company will participate in the 32^nd Annual Oppenheimer Healthcare Conference being held virtually from March 15-17, 2022. President and Chief Executive Officer Stephen Dilly, MBBS, PhD, will provide an overview of the company on Tuesday, March 15, 2022, beginning at 3:20 pm ET.

A replay of the presentation will be available following the conference on the Investors section of Sierra’s corporate website in the Events & Webcast tab. The replay will be available for approximately 30 days following the presentation.

About Sierra Oncology

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. We harness our deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Our team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Together we are transforming promise into patient impact.

For more information, visit www.SierraOncology.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220311005097/en/

Investor Contact



DeDe Sheel

415.732.9828

dsheel@sierraoncology.com



Media Contact



Lauren Musto

615.351.7777

lmusto@sierraoncology.com

Source: Sierra Oncology

FAQ

When is Sierra Oncology's presentation at the Oppenheimer Healthcare Conference?

Sierra Oncology's presentation is scheduled for March 15, 2022, at 3:20 PM ET.

Where can I watch the replay of Sierra Oncology's conference presentation?

The replay of Sierra Oncology's presentation will be available on their corporate website in the Events & Webcast section for 30 days after the conference.

What is Sierra Oncology's focus in the biopharmaceutical industry?

Sierra Oncology focuses on delivering targeted therapies for rare forms of cancer, utilizing deep scientific expertise to advance innovative treatments.

Who is the CEO of Sierra Oncology?

The CEO of Sierra Oncology is Stephen Dilly, MBBS, PhD.

What is the stock symbol for Sierra Oncology?

The stock symbol for Sierra Oncology is SRRA.